• Description and indication for use

    Insulin is a protein hormone formed by the beta cells of the Islets of Langerhans of the pancreas and secreted into the blood, where it regulates carbohydrate, lipid and amino acid metabolism.

    Insulin is used to maintain normoglycaemia in infants with persistent glucose intolerance and as adjuvant therapy in the treatment of hyperkalaemia in critically ill infants.

    Dose

    Hyperglycaemia

    SC:

    0.05 to 0.2 units/kg – 4 to 6 hourly.

    IV Infusion:

    0.01 to 0.1 units/kg/hour.  Monitor blood glucose at least every 30 minutes initially.

    Titrate infusion according to blood glucose results.

    Hyperkalaemia

    IV:

    0.1 units/kg with 2 mL/kg of Glucose 50%.

    Reconstitution/Dilution

    Vial = 100 units/mL (Refrigerate).

    SC:

    Dilute to 1 unit/mL with saline, as described: withdraw Insulin 100 units/mL solution and add to sodium chloride 0.9% in a second syringe as shown in the table below:

    Volume Of Insulin 100 units/mL Volume of Sodium chloride 0.9% Final Volume Final Concentration**
    0.1 mL 0.9 mL 1 mL 10 units/mL
    0.1 mL 1.9 mL 2 mL 5 units/mL
    0.1 mL 9.9 mL 10 mL 1 unit/mL

    **The dilution that enables measurement of the dose with minimum volume should be used.

    NB.  For withdrawing and giving actual dose please refer to Method of Administration (over the page).

    IV infusion:        

    Withdraw required dose and make up to ordered volume of infusion fluid.

    Add 5 units/kg Insulin to 50 mL of infusion solution and infuse at 1 mL/hr to give 0.1 units/kg/hour.

    If amount to be added to the infusion solution is not measurable at 100 units/mL, a dilution can be made as follows:

    Withdraw 0.1 mL of 100 units/mL solution and add to 0.9 mL of sodium chloride 0.9% in a second 1 mL syringe = 10 units/mL

    Drug How to make up Dose equivalent Dose range
    Insulin 5 units/kg in 50 mL 1 mL/hr = 0.1 units/kg/hr 0.02 to 0.1 units/kg/hr

    Infusion solution should be changed every 24 hours.

    Draw up 0.9mL of Albumin 20% and add to 49.1mL of infusion solution (this will minimise the loss of insulin through adherence to syringe and line).

    For hyperglycaemia use Sodium chloride 0.9%, or Glucose 5% as the infusion solution.                                                           

    Route and method of administration

    SC:

    Use Insulin syringe to withdraw dose and give SC injection.

    IV infusion:

    Give at ordered rate via syringe pump.

    Side effects

    Hypoglycaemia (sweating, tachycardia), hyperinsulinism, hypokalaemia.

    Compatible Solutions

    Fluids:

    Sodium Chloride 0.9%, Glucose 10%, Glucose 5%, TPN, Intralipid.

    Drugs:

    Ranitidine.

    Via Y-site:  Dobutamine, Gentamicin, Heparin, Imipenem, Magnesium Sulphate, Morphine, Potassium Chloride, Ticarcillin-Clavulanate, Tobramycin, Vancomycin.

    When giving an infusion for hyperglycaemia, it is best to give the insulin in Sodium Chloride 0.9% or Sodium Chloride 0.45%.

    Incompatibilities

    Fluids:

    No information.

    Drugs:

    Aminophylline, Bbenzylpenicillin, Digoxin, Dobutamine, Sodium Bicarbonate, Phenytoin.

    Insulin is incompatible with many drugs.

    Other drugs or solutions must not be bolused via the insulin line.

    Administer alone or contact pharmacy for further information.

    Drug interactions

    Propranolol May increase the effect of Insulin.
    Corticosteroids, Chlorothiazide, Adrenaline, Glucagon, Phenytoin May decrease the effect of Insulin.

    Nursing responsibilities

    Monitor heart and respiratory rate.

    Monitor blood glucose at least every 30 minutes following commencement of infusion, then 2 to 4 hourly initially, then as necessary.

    Test urine for glucose once per shift.

    Strictly avoid giving boluses of Insulin, infuse alone.

    Monitor blood glucose 1 hour after any increase in infusion rate.

    Check that infusion rate corresponds to required dose (units/kg/hr).

Disclaimer:  This Drug information was designed for use by PIPER Neonatal. Whilst great care has been taken to check the information is accurate, it is possible that errors may have been missed. Furthermore, dosage schedules are continually being revised and new side effects recognised. For these reasons, the reader is strongly advised to consult the drug companies' printed information before administering any of the drugs recommended in this book.
Most drugs in this document are appropriate only for specialist use in hospitals.  A number of drugs should only be used in consultation with the appropriate Paediatric subspecialist. 

Note: The electronic version of this guideline is the version currently in use.  Any printed version cannot be assumed to be current. Printed copies of this document are valid for